Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-303316
Filing Date
2026-07-14
Accepted
2026-07-14 16:50:19
Documents
86
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-K vivs-20260331.htm   iXBRL 10-K 3030486
2 EX-4.5 vivs-ex4_5.htm EX-4.5 58019
3 EX-10.33 vivs-ex10_33.htm EX-10.33 41527
4 EX-21.1 vivs-ex21_1.htm EX-21.1 3604
5 EX-23.1 vivs-ex23_1.htm EX-23.1 4539
6 EX-31.1 vivs-ex31_1.htm EX-31.1 13915
7 EX-31.2 vivs-ex31_2.htm EX-31.2 14897
8 EX-32.1 vivs-ex32_1.htm EX-32.1 10774
9 GRAPHIC img115428739_0.jpg GRAPHIC 54728
  Complete submission text file 0001193125-26-303316.txt   11692313

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vivs-20260331.xsd EX-101.SCH 1732610
90 EXTRACTED XBRL INSTANCE DOCUMENT vivs-20260331_htm.xml XML 1794796
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-35996 | Film No.: 261174794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)